STUDY

All three creams faded melasma about the same; hydroquinone caused more irritation

“Safety and efficacy of niosomal and conventional tranexamic acid/niacinamide vs. hydroquinone creams in melasma: A randomized, double-blind, case-controlled clinical trial.” Ghasemiyeh P et al. Scientific Reports. November 2025

Ghasemiyeh P et al. · Scientific Reports · November 2025

Randomized trial
The finding

In a three-month trial, all three creams improved melasma scores. The study found no clear difference in improvement and reported more reactions with hydroquinone.

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Randomized and double-blind. The study assigned 33 people to each of three creams. Seventy-seven completed treatment.
At a glance

Who was studied and for how long

Randomized
99 people
33 per group
Completed
77 people
69 attended the short follow-up
Length
3 months
Melasma was scored monthly
What they did

How the study worked

99 peoplemelasmaRANDOMSPLITNiosomal TXA + niacinamide33 assigned · 2% + 2%Standard TXA + niacinamide33 assigned · 5% + 4%Hydroquinone33 assigned · 4% creamMEASURED ATMonth 3pigment and melasma score99 peoplemelasmaRANDOMSPLITNiosomal TXA+ niacinamide33 assigned · 2% + 2%Standard TXA+ niacinamide33 assigned · 5% + 4%Hydroquinone33 assigned · 4% creamMEASURED ATMonth 3pigment and melasma score
Assign creamsParticipants received one of two tranexamic acid–niacinamide formulas or 4% hydroquinone.
Track pigmentClinicians assessed darkness and the area affected over three months.
Check after stoppingA smaller group returned for short follow-up.
What they found

The results

Niosomal TXA + niacinamideStandard TXA + niacinamideHydroquinone

Changes in melasma

Melasma and pigment scores improved in all three groups. The study did not find a clear difference between groups over time.

Reported skin reactions

One person in each combination group and six in the hydroquinone group reported a reaction.

Niosomal combination
3.03%
Conventional combination
3.03%
Hydroquinone
18.18%
Overall comparison (p = 0.033)
The study tested complete formulas. It cannot tell how either ingredient works alone or whether the creams have equivalent effects.
How much to trust it

Strengths and limits

Strengths

  • Randomized and double-blind
  • Compared with an active treatment
  • Measured clinical scores and pigment

Limits

  • Twenty-two people did not complete treatment
  • Only three months of treatment and a short follow-up
  • Both comparison creams contained two active ingredients
Moderate confidence. The blinded trial compared three specific formulas, with substantial attrition and limited follow-up.
What it means for you

The takeaway

Three formulas improved scores

The combination creams improved melasma in this trial. Hydroquinone users reported more reactions, but the groups were small.

Pages that cite this study

Read more on Dermapedia

Terms in this study

Words worth knowing

mMASI

A score based on the area and darkness of melasma patches.

Niosomal

Packed in tiny vesicles that can change how ingredients are delivered.

Original source

Ghasemiyeh P, Haghighi NF, Dastgheib L, Ranjbar S, Mohammadi-Samani S. Safety and efficacy of niosomal and conventional tranexamic acid/niacinamide vs. hydroquinone creams in melasma: A randomized, double-blind, case-controlled clinical trial.. Sci Rep. 2025;15(1):42739.

PMID 41315336